TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 3906875

Group type: EXPERIMENTAL
Intervention: Pyrazinamide (Z) combined with Isoniazid (H) and Rifampicin (R)
Number of subjects: 190

Group type: EXPERIMENTAL
Intervention: Ethambutol (E) combined with Isoniazid (H) and Rifampicin (R)
Number of subjects: 190

Group type: EXPERIMENTAL
Intervention: Rifampicin (R) combined with Isoniazid (H)
Number of subjects: 190

Group type: EXPERIMENTAL
Intervention: Ethambutol (E) combined with Isoniazid (H)
Number of subjects: 190

Group type: EXPERIMENTAL
Intervention: Overall treatment
Number of subjects: 190
Study: 31731527

Group type: EXPERIMENTAL
Intervention: Altilix® supplementation
Number of subjects: 100
Study: 29995181

Group type: EXPERIMENTAL
Intervention: Education and motivation instructions in oral health and plaque control
Number of subjects: 38

Group type: COMPARATOR
Intervention: Dental prophylaxis
Number of subjects: 38
Study: 29231293

Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA) at Zusanli (ST 36) and Zhigou (TE 6), 30 min for each treatment, once a day for 5 days.
Number of subjects: 140

Group type: COMPARATOR
Intervention: Regular treatment including intensive care, gastrointestinal decompression, fasting, blood capacity supplement, acid suppression treatment, internal environment maintenance, infection prevention, inhibition of pancreatic exocrine secretion.
Number of subjects: 140
Study: 24351100

Group type: EXPERIMENTAL
Intervention: Low central venous pressure (≤5 mmHg)
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Acute normovolemic hemodilution
Number of subjects: 92

Group type: COMPARATOR
Intervention: Conventional fluid management
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 92
Study: 22078660

Group type: EXPERIMENTAL
Intervention: DHA supplementation (400mg daily) + Calcium (1200mg) + Vitamin D(3) (1000 IU)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo + Calcium (1200mg) + Vitamin D(3) (1000 IU)
Number of subjects: 40
Study: 19606508

Group type: EXPERIMENTAL
Intervention: Acupuncture group (PC6 and ST36 acupoints)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Sham group (1 cm away from PC6 and ST36 acupoints)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Normal group (no acupuncture)
Number of subjects: 30
Study: 17257532

Group type: EXPERIMENTAL
Intervention: Early mobilization in a removable cast
Number of subjects: 62

Group type: COMPARATOR
Intervention: Nonweightbearing below‐knee cast
Number of subjects: 62
Study: 15308515

Group type: EXPERIMENTAL
Intervention: Infliximab (IFX) 3 mg/kg, three i.v. infusions on weeks 0, 2, and 6
Number of subjects: 21

Group type: COMPARATOR
Intervention: Methylprednisolone (MP) 1 g, single i.v. infusion
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Infliximab (IFX)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Methylprednisolone (MP)
Number of subjects: 21
Study: 11468195

Group type: EXPERIMENTAL
Intervention: Cerivastatin (0.15 mg/d for 3 days)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 27
Study: 9543975

Group type: EXPERIMENTAL
Intervention: Hydrogel dressing A
Number of subjects: 50

Group type: COMPARATOR
Intervention: Hydrogel dressing B
Number of subjects: 50
Study: 7820487

Group type: EXPERIMENTAL
Intervention: Brain biopsy (stereotactic and ultrasonographically guided)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Brain biopsy
Number of subjects: 50
Study: 2454980

Group type: EXPERIMENTAL
Intervention: Intralesional injection of 1 U/ml bleomycin sulfate
Number of subjects: 143

Group type: COMPARATOR
Intervention: Physiologic saline solution injection (control)
Number of subjects: 143
Study: 30354905

Group type: EXPERIMENTAL
Intervention: iRest meditation training
Number of subjects: 30

Group type: COMPARATOR
Intervention: Vacation control
Number of subjects: 30
Study: 27690687

Group type: EXPERIMENTAL
Intervention: Metformin 1000 mg daily for 4 weeks, then 1500 mg daily for 8 weeks
Number of subjects: 42

Group type: COMPARATOR
Intervention: Megestrol 40 mg daily for 12 weeks
Number of subjects: 42
Study: 26834024

Group type: EXPERIMENTAL
Intervention: Navigate (NAV)
Number of subjects: 404

Group type: COMPARATOR
Intervention: Community Care (CC)
Number of subjects: 404
Study: 25060103

Group type: EXPERIMENTAL
Intervention: Forgiveness therapy (conducted once a week for 12 weeks)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Forgiveness therapy
Number of subjects: 29

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 29
Study: 22057729

Group type: EXPERIMENTAL
Intervention: Micronized aspirin 500 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Regular aspirin 500 mg tablets
Number of subjects: 0
Study: 19150203

Group type: EXPERIMENTAL
Intervention: Immediate training in motivational interviewing
Number of subjects: 0

Group type: COMPARATOR
Intervention: Delayed training
Number of subjects: 0
Study: 17181460

Group type: EXPERIMENTAL
Intervention: Cookin' Up Health nutrition intervention
Number of subjects: 262

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 262
Study: 15090480

Group type: EXPERIMENTAL
Intervention: Exercise training for 8 weeks
Number of subjects: 43
Study: 12566892

Group type: EXPERIMENTAL
Intervention: Sildenafil (200 mg)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Control (no drug)
Number of subjects: 13
Study: 9640412

Group type: EXPERIMENTAL
Intervention: Growth Hormone (Genotropin) 0.25 IU/Kg/week (0.125 IU/kg/week for the first four weeks)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35
Study: 9404870

Group type: EXPERIMENTAL
Intervention: 20 g of creatine monohydrate per day for 5 consecutive days
Number of subjects: 5

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5
Study: 1789763

Group type: EXPERIMENTAL
Intervention: Valiant‐PhD alloy
Number of subjects: 73

Group type: COMPARATOR
Intervention: Lojic N alloy
Number of subjects: 73
Study: 7059561

Group type: EXPERIMENTAL
Intervention: Chilean mixed diet at protein levels of 0.40, 0.55, and 0.70 g/kg body-weight per day
Number of subjects: 8

Group type: COMPARATOR
Intervention: Egg reference diet providing 0.30, 0.45, and 0.60 g protein/kg per day
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Chilean mixed diet
Number of subjects: 8

Group type: COMPARATOR
Intervention: Egg diet
Number of subjects: 8
Study: 29543548

Group type: EXPERIMENTAL
Intervention: Alcaftadine 0.25%
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Olopatadine 0.1%
Number of subjects: 240

Group type: COMPARATOR
Intervention: Vehicle
Number of subjects: 240
Study: 28689602

Group type: EXPERIMENTAL
Intervention: Malva nut polysaccharide
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Moisturizing gel containing malva nut polysaccharide
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo (vehicle)
Number of subjects: 24
Study: 25724385

Group type: EXPERIMENTAL
Intervention: Cognitive Bias Modification training of Interpretations (CBM-I)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo variant of CBM-I
Number of subjects: 16
Study: 25888685

Group type: EXPERIMENTAL
Intervention: Resilience
Number of subjects: 645

Group type: EXPERIMENTAL
Intervention: Perceived Stigmatization
Number of subjects: 645

Group type: EXPERIMENTAL
Intervention: Resilience (indirect effect)
Number of subjects: 645
Study: 24030571

Group type: EXPERIMENTAL
Intervention: Pre-filled syringe formulation of canakinumab
Number of subjects: 130

Group type: COMPARATOR
Intervention: Reconstituted lyophilized formulation of canakinumab
Number of subjects: 130
Study: 21383323

Group type: EXPERIMENTAL
Intervention: Bilateral subthalamic nucleus deep brain stimulation (STN DBS)
Number of subjects: 9
Study: 19374216

Group type: EXPERIMENTAL
Intervention: COND (circulating-water mattress at 37 degrees C on the back)
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: COND + CONV (circulating-water mattress associated with warm air blanket at 42 degrees C over the thorax and upper limbs)
Number of subjects: 43

Group type: COMPARATOR
Intervention: COND
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: COND + CONV
Number of subjects: 43
Study: 17001467

Group type: EXPERIMENTAL
Intervention: Intravenous glutamine (L-alanyl-L-glutamine 200mg/ml) for 20h at a rate of 0.125ml/kg/h
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 15
Study: 15336470

Group type: EXPERIMENTAL
Intervention: Granisetron 20 microg/kg
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Granisetron 40 microg/kg
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Granisetron 80 microg/kg
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Granisetron 10 microg/kg
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 10930822

Group type: EXPERIMENTAL
Intervention: Atorvastatin (AT)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Pravastatin (PV)
Number of subjects: 39
Study: 9591517

Group type: EXPERIMENTAL
Intervention: 300 mg/day tolcapone
Number of subjects: 379

Group type: EXPERIMENTAL
Intervention: 600 mg/day tolcapone
Number of subjects: 379

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 379
Study: 8023687

Group type: EXPERIMENTAL
Intervention: Obsessive-compulsive behaviors
Number of subjects: 810

Group type: EXPERIMENTAL
Intervention: Scores on compulsive, borderline and histrionic personality disorder scales
Number of subjects: 810
Study: 2682347

Group type: EXPERIMENTAL
Intervention: fenfluramine treatment
Number of subjects: 13
Study: 788768

Group type: EXPERIMENTAL
Intervention: Antibiotic/corticosteroid combination
Number of subjects: 0

Group type: COMPARATOR
Intervention: Antibiotic alone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Corticosteroid alone
Number of subjects: 0
Study: 30650572

Group type: EXPERIMENTAL
Intervention: Walking in a forest for approximately 15 min
Number of subjects: 60

Group type: COMPARATOR
Intervention: Walking in a city area for approximately 15 min
Number of subjects: 60
Study: 28177739

Group type: COMPARATOR
Intervention: Aerobic training
Number of subjects: 304

Group type: COMPARATOR
Intervention: Combined aerobic and resistance training
Number of subjects: 304

Group type: COMPARATOR
Intervention: Resistance training
Number of subjects: 304

Group type: EXPERIMENTAL
Intervention: Non-exercising control
Number of subjects: 304
Study: 24127077

Group type: EXPERIMENTAL
Intervention: Revision concept including débridement, irrigation, and insertion of temporary drainage with hardware retention until healing
Number of subjects: 31
Study: 23463779

Group type: EXPERIMENTAL
Intervention: B2A-coated ceramic granules (Amplex)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Autogenous bone graft
Number of subjects: 24
Study: 21240780

Group type: EXPERIMENTAL
Intervention: Team-based learning (TBL)
Number of subjects: 112

Group type: COMPARATOR
Intervention: Usual small group lecture (SGL)
Number of subjects: 112
Study: 19789014

Group type: EXPERIMENTAL
Intervention: Surgeon-performed ultrasound (SUS)
Number of subjects: 442
Study: 17052087

Group type: EXPERIMENTAL
Intervention: Injury prevention presentation to the injured child's class
Number of subjects: 0

Group type: COMPARATOR
Intervention: Injury prevention presentation to the control class
Number of subjects: 0
Study: 14663474

Group type: EXPERIMENTAL
Intervention: Tamsulosin 0.4 mg once daily
Number of subjects: 403

Group type: COMPARATOR
Intervention: Finasteride 5 mg once daily
Number of subjects: 403

Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 403
Study: 10667628

Group type: EXPERIMENTAL
Intervention: Face-to-face, in-hospital counseling sessions followed by telephone counseling
Number of subjects: 254

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 254

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 254
Study: 9245178

Group type: EXPERIMENTAL
Intervention: Postal questionnaire with stamped return envelope
Number of subjects: 138

Group type: COMPARATOR
Intervention: Postal questionnaire with post-free return envelope
Number of subjects: 138
Study: 8750218

Group type: EXPERIMENTAL
Intervention: Improved glycaemic control after 1 year
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Improved glycaemic control after 3 months
Number of subjects: 12

Group type: COMPARATOR
Intervention: Diagnosis
Number of subjects: 12
Study: 2463912

Group type: EXPERIMENTAL
Intervention: N,N dimethylglycine (DMG) 300 mg/day for the first 14 days, then 600 mg/day
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study: 4934374

Group type: EXPERIMENTAL
Intervention: Cephalexin
Number of subjects: 62

Group type: COMPARATOR
Intervention: Ampicillin
Number of subjects: 62
Study: 31522631

Group type: EXPERIMENTAL
Intervention: Clinician turnover
Number of subjects: 328
Study: 29444268

Group type: EXPERIMENTAL
Intervention: Pictorial tobacco product warning labels (TPWLs)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Novel assessment methods (brain imaging, eye tracking, 'best-worst' discrete choice experiments)
Number of subjects: 0
Study: 28663402

Group type: EXPERIMENTAL
Intervention: Localisation system (Group A)
Number of subjects: 126

Group type: COMPARATOR
Intervention: Conventional means (Group B)
Number of subjects: 126
Study: 26674631

Group type: EXPERIMENTAL
Intervention: Average daily moderate-to-vigorous physical activity (MVPA)
Number of subjects: 417

Group type: EXPERIMENTAL
Intervention: Neighborhood social interaction
Number of subjects: 417
Study: 23323573

Group type: EXPERIMENTAL
Intervention: Written emotional disclosure (WED) interventions
Number of subjects: 77

Group type: COMPARATOR
Intervention: Control writing condition
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: All writing conditions (including WED)
Number of subjects: 77
Study: 22024518

Group type: EXPERIMENTAL
Intervention: TMC435 25 mg
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: TMC435 75 mg
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: TMC435 200 mg
Number of subjects: 111

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: TMC435 (75, 150, or 200 mg) in treatment-experienced patients
Number of subjects: 111

Group type: COMPARATOR
Intervention: Placebo in treatment-experienced patients
Number of subjects: 111
Study: 18200348

Group type: EXPERIMENTAL
Intervention: Electrical muscle stimulation using commercial electrical devices
Number of subjects: 20

Group type: COMPARATOR
Intervention: Voluntary physical activity with loads
Number of subjects: 20
Study: 16465518

Group type: EXPERIMENTAL
Intervention: Randomised controlled trials (RCTs)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non-randomised comparisons
Number of subjects: 0
Study: 12779258

Group type: EXPERIMENTAL
Intervention: Gamma Knife radiation
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Fractionated radiation therapy with a linear accelerator
Number of subjects: 32

Group type: COMPARATOR
Intervention: Conservative management (comparison group)
Number of subjects: 32
Study: 11014390

Group type: EXPERIMENTAL
Intervention: Amitriptyline
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Amitriptyline and fluphenazine
Number of subjects: 49

Group type: COMPARATOR
Intervention: Fluphenazine
Number of subjects: 49

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 49
Study: 9071624

Group type: EXPERIMENTAL
Intervention: Topical bifonazole-urea ointment alone
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Topical bifonazole-urea ointment combined with oral griseofulvin 500 mg
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo (oral treatment)
Number of subjects: 120
Study: 8219113

Group type: EXPERIMENTAL
Intervention: Single daily dose tobramycin (5 mg/kg per day) plus ceftriaxone (2 g/day) (C + T)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Tobramycin (1.5 mg/kg, every 8 h) plus azlocillin (4 g, every 6 h) (A + T)
Number of subjects: 92
Study: 2412051

Group type: COMPARATOR
Intervention: Ketanserin (subacute treatment)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Ketanserin (chronic treatment for 3 months)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 110
Study: 29477133

Group type: EXPERIMENTAL
Intervention: Ultrasound and exercise therapy
Number of subjects: 62

Group type: COMPARATOR
Intervention: Placebo ultrasound and exercise therapy
Number of subjects: 62
Study: 26654350

Group type: EXPERIMENTAL
Intervention: 375 mg amoxicillin and 500 mg metronidazole three times per day for 7 days during the non-surgical treatment phase (T1)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Antibiotics administered during the surgical phase (T2)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 80
Study: 25277807

Group type: EXPERIMENTAL
Intervention: Antimicrobial photodynamic therapy (aPDT)
Number of subjects: 40

Group type: COMPARATOR
Intervention: No additional therapy (placebo group)
Number of subjects: 40
Study: 22247273

Group type: EXPERIMENTAL
Intervention: Closed-loop stimulation (CLS) pacing
Number of subjects: 41

Group type: COMPARATOR
Intervention: Conventional pacing (dual-chamber pacemaker with conventional algorithms)
Number of subjects: 41
Study: 20596067

Group type: EXPERIMENTAL
Intervention: Surgery performed by residents
Number of subjects: 3236

Group type: EXPERIMENTAL
Intervention: Surgery performed by specialists
Number of subjects: 3236
Study: 18578178

Group type: EXPERIMENTAL
Intervention: Dual-cure resin cement
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Glass-ionomer cement
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Preparation at 15 minutes after cementation
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Preparation at 24 hours after cementation
Number of subjects: 48
Study: 15778466

Group type: EXPERIMENTAL
Intervention: 10-min 55 degrees F cool water bath followed by air cooling
Number of subjects: 6

Group type: COMPARATOR
Intervention: Air cooling
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: 10-min 55 degrees F cool water bath
Number of subjects: 6
Study: 12431867

Group type: EXPERIMENTAL
Intervention: Therapeutic drug monitoring (TDM) coupled with Bayesian forecasting (D(a))
Number of subjects: 32

Group type: COMPARATOR
Intervention: Moellering's nomogram (D(M))
Number of subjects: 32
Study: 10512926

Group type: EXPERIMENTAL
Intervention: Intracerebral calcification in systemic sclerosis patients
Number of subjects: 37

Group type: COMPARATOR
Intervention: Control group (age-matched and sex-matched subjects)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Duration of Raynaud's phenomenon in patients
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Age in patients
Number of subjects: 37
Study: 7726273

Group type: EXPERIMENTAL
Intervention: Detailed questioning about recurrent genital symptoms during pregnancy.
Number of subjects: 201

Group type: EXPERIMENTAL
Intervention: Detailed histories on patients without suggestive symptoms or with somewhat suggestive symptoms.
Number of subjects: 201

Group type: EXPERIMENTAL
Intervention: Detailed histories on subjects with highly suggestive symptoms.
Number of subjects: 201

Group type: EXPERIMENTAL
Intervention: Positive predictive values for recurrent genital symptoms.
Number of subjects: 201

Group type: COMPARATOR
Intervention: Asking if the patient has ever had genital herpes.
Number of subjects: 201
Study: 2201163

Group type: EXPERIMENTAL
Intervention: Cefixime
Number of subjects: 364

Group type: COMPARATOR
Intervention: Cefaclor
Number of subjects: 364
Study: 6355617

Group type: EXPERIMENTAL
Intervention: Furosemide (F) 40 mg daily for 3 days
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Captopril (C) 25 mg . 6 hr-1 with Furosemide (F)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Captopril (C) alone
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Furosemide (F) alone and F + C
Number of subjects: 6
Study: 31525489

Group type: EXPERIMENTAL
Intervention: 3-month peer mentorship intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Minimally enhanced usual care condition
Number of subjects: 0
Study: 29247102

Group type: EXPERIMENTAL
Intervention: Without overstatement
Number of subjects: 622

Group type: COMPARATOR
Intervention: With overstatement
Number of subjects: 622
Study: 25916386

Group type: EXPERIMENTAL
Intervention: MRI-PDFF
Number of subjects: 132
Study: 24317204

Group type: COMPARATOR
Intervention: Inspiratory pressure of 10 cm H2O (group P10)
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Inspiratory pressure of 15 cm H2O (group P15)
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Inspiratory pressure of 20 cm H2O (group P20)
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Inspiratory pressure of 25 cm H2O (group P25)
Number of subjects: 67
Study: 22749924

Group type: EXPERIMENTAL
Intervention: Risk Score (RS) based on clinical and histopathological features
Number of subjects: 378
Study: 19470869

Group type: EXPERIMENTAL
Intervention: Systolic Blood Pressure (SBP)
Number of subjects: 11140

Group type: EXPERIMENTAL
Intervention: Pulse Pressure (PP)
Number of subjects: 11140

Group type: EXPERIMENTAL
Intervention: Mean Arterial Pressure (MAP)
Number of subjects: 11140

Group type: EXPERIMENTAL
Intervention: Diastolic Blood Pressure (DBP)
Number of subjects: 11140

Group type: EXPERIMENTAL
Intervention: Achieved blood pressure values
Number of subjects: 11140
Study: 17900460

Group type: EXPERIMENTAL
Intervention: Aspirin prescription
Number of subjects: 28320
Study: 15671918

Group type: EXPERIMENTAL
Intervention: ACEI or ARB (angiotensin converting enzyme inhibitor or angiotensin receptor blocker)
Number of subjects: 76069

Group type: COMPARATOR
Intervention: Placebo or reference drug (beta-blocker or diuretic)
Number of subjects: 76069

Group type: EXPERIMENTAL
Intervention: RAS inhibition (ACEI or ARB)
Number of subjects: 76069

Group type: EXPERIMENTAL
Intervention: ACEIs and ARBs
Number of subjects: 76069

Group type: EXPERIMENTAL
Intervention: RAS inhibition
Number of subjects: 76069
Study: 11485111

Group type: EXPERIMENTAL
Intervention: Continuous Positive Airway Pressure (CPAP) treatment for 1 week
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo CPAP (2 cm H2O with holes in mask)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Overall cognitive functioning posttreatment
Number of subjects: 36
Study: 9506593

Group type: EXPERIMENTAL
Intervention: Thrombolytic therapy with combined streptokinase and tissue plasminogen activator
Number of subjects: 244
Study: 8151411

Group type: EXPERIMENTAL
Intervention: Iodine-123-phenylpentadecanoic acid (IPPA) 2 mCi
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Iodine-123-phenylpentadecanoic acid (IPPA) 4 mCi
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Iodine-123-phenylpentadecanoic acid (IPPA) 6 mCi
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0